IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,200,877 | -22.8% | 263,929 | +19.5% | 0.00% | 0.0% |
Q2 2023 | $1,554,798 | +54.5% | 220,852 | +34.1% | 0.00% | 0.0% |
Q1 2023 | $1,006,238 | -2.4% | 164,687 | +0.9% | 0.00% | 0.0% |
Q4 2022 | $1,030,841 | -32.4% | 163,247 | +2.1% | 0.00% | 0.0% |
Q3 2022 | $1,525,957 | -13.5% | 159,821 | -0.9% | 0.00% | 0.0% |
Q2 2022 | $1,764,264 | +2.3% | 161,200 | +56.0% | 0.00% | 0.0% |
Q1 2022 | $1,725,103 | -19.0% | 103,303 | +45.2% | 0.00% | -50.0% |
Q1 2020 | $2,130,000 | +17.1% | 71,140 | +8.3% | 0.00% | 0.0% |
Q4 2019 | $1,819,000 | +49.0% | 65,705 | -3.2% | 0.00% | +100.0% |
Q3 2019 | $1,221,000 | -26.9% | 67,863 | -0.4% | 0.00% | -50.0% |
Q2 2019 | $1,671,000 | +164.0% | 68,138 | +2.3% | 0.00% | +100.0% |
Q1 2019 | $633,000 | +22.2% | 66,621 | +13.8% | 0.00% | 0.0% |
Q4 2018 | $518,000 | -11.6% | 58,566 | +12.4% | 0.00% | 0.0% |
Q3 2018 | $586,000 | -22.6% | 52,126 | -11.8% | 0.00% | 0.0% |
Q2 2018 | $757,000 | -14.9% | 59,109 | +12.2% | 0.00% | 0.0% |
Q1 2018 | $890,000 | +142.5% | 52,660 | +14.9% | 0.00% | – |
Q4 2017 | $367,000 | +16.1% | 45,817 | +12.6% | 0.00% | – |
Q3 2017 | $316,000 | +2.6% | 40,707 | -2.7% | 0.00% | – |
Q2 2017 | $308,000 | – | 41,835 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |